Search Results - "Vizel, A A"

The Use of Inhaled Glucocorticosteroids (ICS) during the COVID-19 Pandemic by Vizel, A. A., Vizel, I. Yu, Sagdieva, M. K., Yarkaeva, F. F.

“…The article analyzes 46 publications on the use of ICS for COVID-19. Both research results and their discussion by specialists are presented. The expediency of…”
Get full text

Some aspects of application of the combination of formoterol and budesonide: what is changed? by Vizel, A. A., Vizel, I. Yu

“…The use of a combination of the inhaled glucocorticosteroid budesonide and beta2-selective long-acting adrenergic agonist formoterol is recommended for both…”
Get full text

Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation by Vizel, A. A., Vizel, I. Yu

“…Chronic obstructive pulmonary disease (COPD) is a chronic, environmentally mediated disease manifested by broncho-obstructive syndrome, which is not completely…”
Get full text

Analysis of Management of Patients with COVID-19 in a Temporary Infectious Diseases Hospital Deployed on the Facilities of Republican TB Dispensary, the Republic of Tatarstan by Vizel, A. A., Shayakhmetova, S. A., Alekseev, A. P., Vizel, I. Yu, Nikitin, A. V., Galimov, A. A.

“…COVID-19 is a viral infection and its prevalence requires investigation of different co-morbid conditions including tuberculosis, as well as operation of…”
Get full text

12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review by A. A. Vizel, I. Yu. Vizel

“…The article presents an analytical review of the use of aclidinium, formoterol, and combination of aclidinium and formoterol to treat chronic obstructive…”
Get full text

The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy by Avdeev, S N, Aisanov, Z R, Belevsky, A S, Beeh, K M, Vizel, A A, Zyryanov, S K, Ignatova, G L, Kostikas, K, Leshchenko, I V, Ovcharenko, S I, Sinopal’nikov, A I, Titova, O N, Shmelev, E I

“…The main goals of COPD therapy are to achieve clinical stability with minimal clinical manifestations and low risk of relapse. The proposed COPD control…”
Get full text

Assessment of the effect of alpha-tocopherol on the course of newly diagnosed pulmonary sarcoidosis: a comparative study by Vizel, A. A., Culver, D. A., Vizel, I. Yu, Shakirova, G. R., Bakunina, E. A.

“…The objective: to compare the results of follow-up over patients with a mild form of pulmonary sarcoidosis who received alpha-tocopherol and those receiving no…”
Get full text

LEFLUNOMIDE AS A POTENTIAL SECOND-LINE DRUG IN THE TREATMENT OF SARCOIDOSIS by VIZEL, А. А., VIZEL, I. YU

“…Sarcoidosis is systemic granulomatosis of an unknown nature, the course of which varies from spontaneous remission to progression resulting in failure of…”
Get full text

Management of Cough in Patients with Chronic Obstructive Pulmonary Disease: Results of the Multicenter Randomized Placebo-Controlled Clinical Trial by Avdeev, Sergey N, Vizel, Alexander A, Abrosimov, Vladimir N, Zaicev, Andrey A, Ignatova, Galina L, Khamitov, Rustem F, Mikhaylusova, Marina P, Shapovalova, Julia S, Pavlysh, Elena F, Trofimov, Basil I, Emelyanov, Alexander V, Martynenko, Tatiana I, Martynenko, Vladimir A, Kostina, Natalia E, Chizhov, Danila A, Chizhova, Olga Yu, Kuzubova, Natalia A, Makova, Elena V, Makarova, Ekaterina V

“…Chronic cough declines quality of life and increases risk of complications in patients with chronic obstructive pulmonary disease (COPD). Reducing cough…”
Get full text

CHRONIC OBSTRUCTIVE PULMONARY DISEASE – AB INITIO TILL PRESENT (historical literature review) by VIZEL, А. А., VIZEL, I. YU

“…The article presents the literature review devoted to establishment of the definition of chronic obstructive pulmonary disease and its components – chronic…”
Get full text

Characteristics of population of patients with sarcoidiosis in the republic of Tatarstan: the results of multi-year monitoring by I. Yu. Vizel, A. A. Vizel, G. R. Shakirova, G. S. Ganibaeva

“…Sarcoidosis is a systemic epithelioid cell granulomatous disease of unknown etiology, which prevalence has increased over the past three decades. The objective…”
Get full text

Database of patients with sarcoidosis of the Republic of Tatarstan: a retrospective analysis for 50 years by Vizel, A. A., Shakirova, G. R., Vizel, I. Yu, Kudryavtseva, E. Z., Burchagina, A. S., Vorobyova, N. B., Gizatullina, E. D., Igonina, O. A., Rakhimzyanov, A. R., Filatova, M. S., Tsyplenkova, R. R., Shaimuratov, R. I.

“…Background: Sarcoidosis is a granulomatous disease with no established etiology. The prevalence of sarcoidosis is growing, there are changes in the clinic of…”
Get full text

Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board by Avdeev, Sergey N., Emelyanov, Alexander V., Aisanov, Zaurbek R., Sinopalnikov, Alexander I., Fomina, Daria S., Nenasheva, Natalia M., Leshchenko, Igor V., Zaikova-Khelimskaia, Irina V., Vizel, Alexander A., Demko, Irina V., Shaporova, Nataliia L., Shulzhenko, Larisa V., Shabanov, Evgeny A.

“…Asthma and chronic obstructive pulmonary disease remain major problems of medicine, and still there is need to improve the level and quality of diagnosis of…”
Get full text

CHRONIC OBSTRUCTIVE PULMONARY DISEASE. MODERN APPROACHES TO THERAPY by A. A. VIZEL, I. Y. VIZEL, E. A. BAKUNINA

“…Data of the most recent achievements in diagnostics and therapy of chronic obstructive pulmonary disease (COPD) from positions of division by phenotypes and…”
Get full text

Characteristics of patients with sarcoidosis who referred to a pulmonologist during the COVID-19 pandemic by Vizel, A. A., Vizel, I. Yu, Shakirova, G. R., Vizel, L. A.

“…Introduction. During the COVID-19 pandemic, the first experience was gained in managing patients with sarcoidosis in the face of a dangerous viral infection, a…”
Get full text

X-ray, laboratory, and functional parallels in intrathoracic sarcoidosis by Vizel, I Yu, Vizel, A A, Shaimuratov, R I

“…to compare respiratory function and laboratory data with the radiographic stages of intrathoracic sarcoidosis. Three hundred and eleven patients (70.4% for…”
Get full text

Chronic obstructive pulmonary disease: in search of effective ways of control by A. A. Vizel, I. U. Vizel

“…According to the WHO, chronic obstructive pulmonary disease is the leading cause of death in the world. Over the past three years, the concept of chronic…”
Get full text

EVALUATION OF MAINTENANCE OF PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE AIMED AT HOSPITALIZATION IN PULMUNOLOGIC DEPARTMENTS OF KAZAN by A. A. Vizel, I. N. Salakhova, I. Y. Vizel, A. R. Vafina, V. I. Ilyinsky, E. Z. Kudryavtseva, V. A. Sergeev

“…Relevance of work. Chronic obstructive pulmonary disease (COPD) is a subject of many international studies, which leads to permanent renewal of clinical…”
Get full text

Expert Panel Resolution on Personified Choice of an Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Diseas by Emelyanov, A V, Avdeev, S N, Aisanov, Z R, Vizel, A A, Ilina, N I, Knyazheskaya, N P, Leshchenko, I V, Nenasheva, N M, Styrt, E A, Titova, O N

Get full text

Fibrous lung tissue lesions: treatment opportunities for post-COVID-19 patients by Aleksandr V. Zhestkov, Rustem F. Khamitov, Aleksandr A. Vizel, Maksim O. Zolotov

“…The article presents the analysis of scientific databases eLIBRARY, PubMed, Scopus on the topic of COVID-19 adverse outcomes and the treatment methods for…”
Get full text